Cargando…

In silico recognition of a prognostic signature in basal-like breast cancer patients

BACKGROUND: Triple-negative breast cancers (TNBCs) display poor prognosis, have a high risk of tumour recurrence, and exhibit high resistance to drug treatments. Based on their gene expression profiles, the majority of TNBCs are classified as basal-like breast cancers. Currently, there are not avail...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conte, Federica, Sibilio, Pasquale, Grimaldi, Anna Maria, Salvatore, Marco, Paci, Paola, Incoronato, Mariarosaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8846521/ https://www.ncbi.nlm.nih.gov/pubmed/35167614 http://dx.doi.org/10.1371/journal.pone.0264024

Ejemplares similares

The New Paradigm of Network Medicine to Analyze Breast Cancer Phenotypes
por: Grimaldi, Anna Maria, et al.
Publicado: (2020)

Prognostic and Clinicopathological Significance of MiR-155 in Breast Cancer: A Systematic Review
por: Grimaldi, Anna Maria, et al.
Publicado: (2020)

miRNA-Based Therapeutics in Breast Cancer: A Systematic Review
por: Grimaldi, Anna Maria, et al.
Publicado: (2021)

Identification of Potential Repurposable Drugs in Alzheimer’s Disease Exploiting a Bioinformatics Analysis
por: Fiscon, Giulia, et al.
Publicado: (2022)

An integrative in-silico analysis discloses a novel molecular subset of colorectal cancer possibly eligible for immune checkpoint immunotherapy
por: Sibilio, Pasquale, et al.
Publicado: (2022)

In silico drug repurposing in COVID-19: A network-based analysis
por: Sibilio, Pasquale, et al.
Publicado: (2021)

Clinical Translatability of “Identified” Circulating miRNAs for Diagnosing Breast Cancer: Overview and Update
por: Grimaldi, Anna Maria, et al.
Publicado: (2019)

Discovering Common miRNA Signatures Underlying Female-Specific Cancers via a Machine Learning Approach Driven by the Cancer Hallmark ERBB
por: Pane, Katia, et al.
Publicado: (2022)

Urinary miRNAs as a Diagnostic Tool for Bladder Cancer: A Systematic Review
por: Grimaldi, Anna Maria, et al.
Publicado: (2022)

A Complex Radiomic Signature in Luminal Breast Cancer from a Weighted Statistical Framework: A Pilot Study
por: Castaldo, Rossana, et al.
Publicado: (2022)

StaRTrEK:in silico estimation of RNA half-lives from genome-wide time-course experiments without transcriptional inhibition
por: Conte, Federica, et al.
Publicado: (2022)

An Integrative Computational Approach Based on Expression Similarity Signatures to Identify Protein–Protein Interaction Networks in Female-Specific Cancers
por: Pane, Katia, et al.
Publicado: (2020)

Usefulness of Traditional Serum Biomarkers for Management of Breast Cancer Patients
por: Mirabelli, Peppino, et al.
Publicado: (2013)

Radiogenomic Analysis of Oncological Data: A Technical Survey
por: Incoronato, Mariarosaria, et al.
Publicado: (2017)

Identification of the prognostic value of Th1/Th2 ratio and a novel prognostic signature in basal-like breast cancer
por: Xiao, Yu, et al.
Publicado: (2023)

SWIM tool application to expression data of glioblastoma stem-like cell lines, corresponding primary tumors and conventional glioma cell lines
por: Fiscon, Giulia, et al.
Publicado: (2018)

DCE-MRI Pharmacokinetic-Based Phenotyping of Invasive Ductal Carcinoma: A Radiomic Study for Prediction of Histological Outcomes
por: Monti, Serena, et al.
Publicado: (2018)

Computational identification of specific genes for glioblastoma stem-like cells identity
por: Fiscon, Giulia, et al.
Publicado: (2018)

A Gene Signature for Predicting Outcome in Patients with Basal-like Breast Cancer
por: Hallett, Robin M., et al.
Publicado: (2012)

Circulating miRNAs in Untreated Breast Cancer: An Exploratory Multimodality Morpho-Functional Study
por: Incoronato, Mariarosaria, et al.
Publicado: (2019)

Publisher Correction: Computational identification of specific genes for glioblastoma stem-like cells identity
por: Fiscon, Giulia, et al.
Publicado: (2018)

Gene expression signatures of morphologically normal breast tissue identify basal-like tumors
por: Finak, Greg, et al.
Publicado: (2006)

A clinically relevant gene signature in triple negative and basal-like breast cancer
por: Rody, Achim, et al.
Publicado: (2011)

Embryonic mammary signature subsets are activated in Brca1(-/- )and basal-like breast cancers
por: Zvelebil, Marketa, et al.
Publicado: (2013)

Transcriptomic immunologic signature associated with favorable clinical outcome in basal-like breast tumors
por: Martínez-Canales, Sandra, et al.
Publicado: (2017)

Alzheimer’s disease: insights from a network medicine perspective
por: Conte, Federica, et al.
Publicado: (2022)

Biobanking in health care: evolution and future directions
por: Coppola, Luigi, et al.
Publicado: (2019)

miR-622 is a novel potential biomarker of breast carcinoma and impairs motility of breast cancer cells through targeting NUAK1 kinase
por: Orlandella, Francesca Maria, et al.
Publicado: (2020)

Diagnostic SOX10 gene signatures in salivary adenoid cystic and breast basal-like carcinomas
por: Ivanov, S V, et al.
Publicado: (2013)

Screening potential immune signatures for early-stage basal-like/triple-negative breast cancer
por: Wu, Min, et al.
Publicado: (2022)

Are Basal-Like and Non-Basal-Like Triple-Negative Breast Cancers Really Different?
por: Dogra, Atika, et al.
Publicado: (2020)

Biomarkers for Basal-like Breast Cancer
por: Choo, Jennifer R., et al.
Publicado: (2010)

Ductal keratin 15(+) luminal progenitors in normal breast exhibit a basal-like breast cancer transcriptomic signature
por: Kohler, Katharina Theresa, et al.
Publicado: (2022)

Role of the long non-coding RNA PVT1 in the dysregulation of the ceRNA-ceRNA network in human breast cancer
por: Conte, Federica, et al.
Publicado: (2017)

In silico screening using bulk and single-cell RNA-seq data identifies RIMS2 as a prognostic marker in basal-like breast cancer: A retrospective study
por: Zhang, Lingyun, et al.
Publicado: (2021)

CD8(+ )lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer
por: Liu, Shuzhen, et al.
Publicado: (2012)

High cyclin E1 protein, but not gene amplification, is prognostic for basal‐like breast cancer
por: Aziz, Diar, et al.
Publicado: (2022)

Genomic Signatures of Immune Activation Predict Outcome in Advanced Stages of Ovarian Cancer and Basal-Like Breast Tumors
por: Alcaraz-Sanabria, Ana, et al.
Publicado: (2020)

Unraveling the complexity of basal-like breast cancer
por: Marotta, Lauren L. C., et al.
Publicado: (2011)

Immunohistochemical characteristics of basal-like breast cancer
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ocgv6rvq3ohcfqvkdrlg3kbg5l